AnalyzeDirect Eirin A, Williams BJ, Ebrahimi B, Zhang X, Crane JA, Lerman A, Textor SC, Lerman LO. Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension. J Hypertens. January 2014;32(1):154-165.
Full Text – Open Access
Publication Date
January 2014
How Analyze was Used
“Left ventricular muscle mass (LVMM), cardiac output, early (E) and late (A) ventricular filling rates, and E/A ratio were calculated [Rodriguez-Porcel et al. 2004, Zhu et al. 2007]. The images were analyzed with the Analyze software package.”
Keywords
Angioplasty
Animals
Apoptosis
Cardiomyopathies/drug therapy/etiology/pathology
Collagen/metabolism
Female
Fibrosis
Heart Function Tests
Hypertension, Renovascular/complications/metabolism/therapy
Kidney Function Tests
Microvessels/ultrastructure
Mitochondria, Heart/metabolism
Oxidative Stress
Oxygen/metabolism
Peptides/metabolism/pharmacology
Swine
Author Affiliation(s)
Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN, US. (AE, BJW, BE, XZ, JAC, SCT, LOL)
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, US. (AL, LOL)
ID# 2690
Tags: Angioplasty, Animals, Apoptosis, Cardiomyopathies/drug therapy/etiology/pathology, Collagen/metabolism, Female, Fibrosis, Heart Function Tests, Heart Mitochondria/metabolism, Kidney Function Tests, Microvessels/ultrastructure, Oxidative Stress, Oxygen/metabolism, Peptides/metabolism/pharmacology, Renovascular Hypertension/complications/metabolism/therapy, Swine